Join the Cardiomyopathy group to help and get support from people like you.
Cardiomyopathy News
Related terms: Cardiomyopathy, dilated, Cardiomyopathy, peripartum, Dilated Cardiomyopathy, Peripartum Cardiomyopathy
AI-Enabled Stethoscope Boosts Diagnosis of Pregnancy-Related Cardiomyopathy
TUESDAY, Sept. 10, 2024 – In pregnant and postpartum women, artificial intelligence (AI)-guided screening using a digital stethoscope improves the diagnosis of pregnancy-related cardiomyopathy,...
New 'AI Stethoscope' Can Spot Pregnancy-Linked Heart Failure
THURSDAY, Sept. 5, 2024 – An AI-enhanced digital stethoscope can help doctors detect a potentially deadly form of heart failure that can occur late in pregnancy, a new clinical trial reports. The...
Aficamten Beneficial for Obstructive Hypertrophic Cardiomyopathy
THURSDAY, May 16, 2024 – Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly greater improvement in peak oxygen uptake compared with placebo among patients...
Guidelines Developed for Management of Hypertrophic Cardiomyopathy
THURSDAY, May 9, 2024 – In a new clinical guideline issued by the American College of Cardiology and the American Heart Association and published online May 8 in the Journal of the American College...
ACC: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
THURSDAY, March 28, 2024 – Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD) have an increased risk for cardiomyopathy, with the risk increasing with...
ADHD Meds Tied to Heart Damage in Young Adult Users
WEDNESDAY, March 27, 2024 – ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk grows with time,...
Calculator Can Help Tailor Treatment During, After Heart Pump Placement
MONDAY, Feb. 5, 2024 – The right ventricular failure (RVF) risk score, STOP-RVF calculator, can predict RVF after durable left ventricular assist device (LVAD) placement, according to a study...
Acoramidis Beneficial in Transthyretin Amyloid Cardiomyopathy
THURSDAY, Jan. 11, 2024 – Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin...